Related Experiment Videos
Plasma renin activity and mineralocorticoid replacement therapy in congenital adrenal hyperplasia
Insights
Plasma renin activity is a superior indicator of mineralocorticoid deficiency in children with congenital adrenal hyperplasia compared to serum electrolytes. Monitoring renin activity helps manage sodium balance during treatment.
Area of Science:
- Pediatric Endocrinology
- Endocrinology
- Biochemistry
Background:
- Congenital adrenal hyperplasia (CAH) due to steroid-21-hydroxylase deficiency requires careful management of mineralocorticoid status.
- Monitoring sodium balance is crucial for patients, especially those with the salt-losing form of CAH.
Purpose of the Study:
- To evaluate plasma renin activity (PRA) and serum electrolytes for monitoring sodium balance in children with CAH.
- To assess the effectiveness of deoxycorticosterone acetate (DOCA) pellet implantation and dietary sodium adjustments in managing mineralocorticoid deficiency.
Main Methods:
- Repeated measurements of plasma renin activity, serum sodium, and serum potassium in seven children with CAH.
- Subcutaneous implantation of deoxycorticosterone acetate (DOCA) pellets.
- Adjustments in dietary sodium intake.
Main Results:
- Infants with salt-losing CAH showed high PRA levels after initial DOCA pellet implantation.
- Repeated DOCA pellet implantation normalized elevated PRA in infants.
- Increased dietary sodium intake normalized moderately elevated PRA in older children with CAH.
- PRA levels were more sensitive to mineralocorticoid deficiency than serum electrolytes.
Conclusions:
- Plasma renin activity is a more reliable index of mineralocorticoid deficiency in children with CAH than serum electrolyte concentrations.
- PRA monitoring is essential for optimizing treatment and managing sodium balance in pediatric CAH patients.
Abstract:
Plasma renin activity and serum concentrations of sodium and potassium were repeatedly measured in seven children with congenital adrenal hyperplasia due to steroid-21-hydroxylase deficiency, to monitor the sodium balance during treatment. Infants with the salt-losing form had high plasma renin activity levels 5--11 months after subcutaneous implantation of a pellet containing 100 mg deoxycorticosterone acetate. These elevated plasma renin activity levels were suppressed to the normal range by repeated implantation of DOCA pellet. Moderately elevated values of plasma renin activity in older salt-losers normalized after increasing the dietary sodium intake. Plasma renin activity level has superiority over serum electrolyte concentrations as an index of mineralocorticoid deficiency.